𝔖 Bobbio Scriptorium

✦ LIBER ✦

Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer

✍ Scribed by Ana P. Kiess; Heather L. McArthur; Kathleen Mahoney; Sujata Patil; Patrick G. Morris; Alice Ho; Clifford A. Hudis; Beryl McCormick

Book ID: 112066855
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 876 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26484

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant Trastuzumab Reduces Locoregiona

Adjuvant Trastuzumab Reduces Locoregional Recurrence in Women Who Receive Breast-Conservation Therapy for Lymph Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

✍ Register, S.; Wright, J.L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Seven-Year Follow-Up Assessment of Cardi

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

✍ Zibelman, M.; Goldstein, L.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB